Meropenem Pregnancy and Breastfeeding Warnings

Meropenem is also known as: Merrem, Merrem Novaplus

Meropenem Pregnancy Warnings

Meropenem has been assigned to pregnancy category B by the FDA. Animal studies have failed to reveal evidence of embryotoxicity or teratogenicity, although slight changes in fetal body weight were noted. There are no controlled data in human pregnancies. Meropenem should only be given during pregnancy when need has clearly been established.

Meropenem Breastfeeding Warnings

A mother was treated with meropenem 1 g IV every 8 hours for 7 days while her newborn was exclusively breastfed. Five samples of hindmilk were collected and the average breast milk level was 480 mcg/L. Estimated average and maximum infant intake were 71 mcg/kg/day (0.13% of weight-adjusted maternal dose) and 97 mcg/kg/day (0.18% of weight-adjusted maternal dose), respectively. When asked later, the mother stated her infant had no symptoms of oral thrush, watery diarrhea, or diaper dermatitis that needed antifungal therapy during therapy or during the month after finishing meropenem.

Caution is recommended. Excreted into human milk: Yes Excreted into animal milk: Data not available Meropenem has been used without apparent harmful effects in the nursing infant; clinical monitoring of infants for altered gastrointestinal flora suggested.

See Also...

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.

Hide
(web4)